Vaxcyte, Inc. Cash Flow Statement

Cash Flow Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -34.70M-53.56M-89.34M-103.33M-223.90M-405.13M-459.55M
Share-based Compensation 0.75M1.19M5.43M10.73M23.65M48.76M84.82M
Gains from Investment Securities -0.00M-0.01M7.80M18.90M0.86M3.88M14.29M
Asset Writedowns and Impairment 0.30M0.21M
Cash from Operations -30.47M-47.15M-46.63M-121.39M-170.60M-296.79M-452.63M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 1.66M6.62M34.77M38.70M
Depreciation & Amortization (CF) 1.04M1.23M1.41M1.80M2.83M3.16M7.00M
Change in Working Capital
Change in Account Payables 1.27M0.87M26.10M-12.47M2.90M11.22M34.58M
Change in Accured Expenses 0.54M-0.78M2.21M4.63M7.17M36.30M-35.65M
Other Working Capital Changes 0.41M1.07M0.07M12.86M1.15M33.01M41.89M
Investing Activities
Capital Expenditures 1.77M1.20M1.16M6.55M5.84M16.06M22.43M
Sales of Property, Plant and Equipment 0.00M0.05M0.03M0.01M
Change in Acquisitions & Divestments 100.50M168.69M611.88M1133.23M
Cash from Investing Activities -1.77M-1.20M-1.10M-212.31M74.58M-773.31M-2005.67M
Financing Activities
Other financing activities 1.10M0.86M3.88M
Cash from Financing Activities 62.19M41.57M374.87M17.80M861.55M639.81M2448.51M
Additional items
Exchange Rate Effect -0.34M0.09M-0.44M0.14M-6.69M0.43M
Change in Cash 29.95M-7.11M327.22M-316.34M765.67M-436.97M-9.36M
Free Cash Flow -32.24M-48.34M-47.78M-127.95M-176.44M-312.85M-475.05M
Net Cash Flow 29.95M-6.77M327.14M-315.90M765.53M-430.29M-9.79M